Pulmonary Arterial Hypertension associated with Neurofibromatosis Type 1
Imaging findings
CT in a patient with known NF-1 demonstrates multiple cutaneous neurofibromas on the skin, prominent pulmonary arteries indicating pulmonary hypertension, and a few scattered small pulmonary cysts. Perivascular haziness is noted.
Key takeaways
Neurofibromatosis type 1 (NF-1) is a rare but recognized cause of pulmonary arterial hypertension (PAH), occurring more frequently in NF-1 patients than in the general population. The mechanism is thought to involve a vasculopathy related to NF-1 gene dysfunction in vascular smooth muscle cells. NF-1-associated PAH should be considered in patients with NF-1 presenting with dyspnea or right heart strain.
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Midesophageal Traction DiverticulumOther
- Iatrogenic Pulmonary Infarction after MetastasectomyIatrogenic
- Iatrogenic Left Hemidiaphragm Injury with GastrothoraxIatrogenic
- Caseous Mitral Annular CalcificationOther
- Multiple Coexisting Pulmonary Pathologies (Adenocarcinoma, Meningothelial-Like Nodules, Carcinoid Tumorlets, and Lymphoma)Neoplastic
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH) with Pulmonary Artery Compression of Left Coronary ArteryVascular
- Aspirated Calcium Supplement Tablet (Endobronchial Foreign Body)Other
- Chest Wall Lipoma and Pulmonary Hamartoma (Complete versus Incomplete Border Sign)Neoplastic
See all cases from April 2, 2021 →
Related Vascular cases
- Type A Aortic Intramural Hematoma Misdiagnosed as Aortitis
- Hepatopulmonary Syndrome Type 2 with Pulmonary Vascular Nodules
- Aortic Intramural Hematoma with Ulcer-Like Projection
- Pulmonary Infarction (Blood-Orange Pattern)
- Concurrent Type A Aortic Dissection with Pulmonary Embolism
- Limited (Incomplete) Aortic Dissection with Progressive Evolution